Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 9;8(1):91.
doi: 10.1038/s41421-022-00454-7.

Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs

Dengyuan Liu #  1 , Peng Wu #  2 , Wentao Gu #  2 , Cuihong Yang  2 , Xinmeng Yang  1 , Xingyu Deng  1 , Jun Xu  3 , Jingmei Jiang  4 , Chengyu Jiang  5
Affiliations

Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs

Dengyuan Liu et al. Cell Discov. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Outcome and efficacy of drugs in hospitalized patients with COVID-19.
a Outcome (28/30-day mortality) and efficacy of telmisartan, losartan, and 11 drugs recommended by China, FDA, EMA and WHO. b Outcome (21/28/30-day mortality) and efficacy of drugs in hospitalized patients admitted to ICU. c Outcome (28/30-day mortality) and efficacy of drugs in hospitalized patients undergoing invasive mechanical ventilation. d Outcome (28/30-day mortality) and efficacy of drugs in hospitalized patients receiving oxygen only. e Outcome (14/15-day mortality) and efficacy of drugs in hospitalized patients. f Outcome (21-day mortality) and efficacy of drugs in hospitalized patients.
See this image and copyright information in PMC

References

    1. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/ (2022).
    1. Kuba K, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 2005;11:875–879. doi: 10.1038/nm1267. - DOI - PMC - PubMed
    1. Sun Y, et al. Cationic nanoparticles directly bind angiotensin-converting enzyme 2 and induce acute lung injury in mice. Part Fibre Toxicol. 2015;12:4. doi: 10.1186/s12989-015-0080-x. - DOI - PMC - PubMed
    1. Yan Y, et al. Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse. Sci. China Life Sci. 2015;58:208–211. doi: 10.1007/s11427-015-4814-7. - DOI - PMC - PubMed
    1. Yang P, et al. Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury. Sci. Rep. 2014;4:7027. doi: 10.1038/srep07027. - DOI - PMC - PubMed